Cure Leukaemia helps to bring pioneering drug and transplant treatments to blood cancer patients throughout the Midlands. The charity helps to finance The Centre for Clinical Haematology at the Queen Elizabeth Hospital in Birmingham, which performs life-saving clinical trials to treat terminally ill leukaemia patients.
Cure Leukaemia’s high-profile roster of supporters includes Deloitte, Pinsent Masons, OGL Computer, Aston Villa Football Club and Warwickshire County Cricket Club, and this was expanded recently by the addition of IBMS Company Member The Binding Site – the first charity partner to introduce payroll donations.
James McLaughlin, Cure Leukaemia’s CEO (pictured with The Binding Site’s CEO Charles de Rohan), said: “We’re delighted to have been recognised by a company that is achieving global excellence. The company's charity committee has some fantastic fundraising activities lined up and we’re very much looking forward to working with its members to help us reach our £1 million fundraising target for the year ahead.”
www.cureleukaemia.co.uk